Atai Life Sciences Return on Investment 2020-2024 | ATAI

Current and historical return on investment (ROI) values for Atai Life Sciences (ATAI) over the last 10 years.
Atai Life Sciences ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-03-31 $-0.12B $0.24B -45.70%
2023-12-31 $-0.13B $0.26B -48.60%
2023-09-30 $-0.13B $0.29B -49.29%
2023-06-30 $-0.14B $0.23B -52.17%
2023-03-31 $-0.14B $0.26B -49.23%
2022-12-31 $-0.14B $0.28B -45.35%
2022-09-30 $-0.15B $0.31B -43.90%
2022-06-30 $-0.15B $0.32B -38.19%
2022-03-31 $-0.17B $0.36B -40.61%
2021-12-31 $-0.14B $0.39B -37.01%
2021-09-30 $-0.18B $0.46B -60.51%
2021-06-30 $-0.15B $0.49B -85.55%
2021-03-31 $-0.10B $0.12B -174.55%
2020-12-31 $-0.10B $0.10B -424.49%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.275B $0.000B
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $18.162B 10.99
Quest Diagnostics (DGX) United States $16.508B 17.06
DaVita (DVA) United States $12.078B 15.00
Encompass Health (EHC) United States $8.774B 22.46
Chemed (CHE) United States $8.268B 25.63
Elanco Animal Health (ELAN) United States $6.548B 16.99
Option Care Health (OPCH) United States $5.428B 20.55
RadNet (RDNT) United States $4.814B 100.25
Amedisys (AMED) United States $3.194B 22.62
Astrana Health (ASTH) United States $2.853B 38.60
Addus HomeCare (ADUS) United States $2.223B 28.77
LifeStance Health (LFST) United States $2.164B 0.00
U.S Physical Therapy (USPH) United States $1.487B 39.79
Pennant (PNTG) United States $0.823B 43.48
Aveanna Healthcare Holdings (AVAH) United States $0.708B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.027B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.020B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00